MEI Pharma Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jay File
Chief executive officer
US$655.7k
Total compensation
| CEO salary percentage | 68.6% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.1yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 17
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)
Dec 30Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)
Nov 19We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022
Mar 26Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts
Feb 12MEI Pharma: Another PI3K Delta Progressing To The FDA
Feb 01Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates
Dec 02We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04MEI Pharma EPS misses by $0.12, misses on revenue
May 06MEI Pharma promotes Richard Ghalie to chief medical officer
Apr 30MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued
Apr 26The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 11
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$47m |
| Jun 30 2024 | US$656k | US$450k | US$18m |
Compensation vs Market: Jay's total compensation ($USD655.65K) is about average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Insufficient data to compare Jay's compensation with company performance.
CEO
Jay File (54 yo)
1.3yrs
Tenure
US$655,650
Compensation
Mr. Justin J. File, also known as Jay, serves as CFO & Corporate Secretary at MEI Pharma, Inc. since August 01, 2023 and serves as its Acting Chief Executive Officer from August 01, 2024. He had been an Ex...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Acting CEO | 1.3yrs | US$655.65k | no data | |
| Senior Vice President of Operations & Quality | 1.3yrs | no data | no data | |
| Vice President of Legal Affairs | 1.8yrs | no data | no data | |
| Chief People Officer | 2.4yrs | no data | no data | |
| Strategic Advisor | 13.4yrs | US$755.98k | no data | |
| Senior Vice President of Corporate Affairs | 3.5yrs | no data | no data |
2.1yrs
Average Tenure
Experienced Management: MEIP's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairperson | 6.8yrs | US$117.20k | 0.028% $ 5.3k | |
| Independent Non-Executive Director | 11.4yrs | US$122.78k | 0% $ 0 | |
| Independent Non-Executive Director | 11.8yrs | US$115.28k | 0.0075% $ 1.4k | |
| Independent Non-Executive Director | 1.1yrs | US$112.40k | 0.14% $ 26.3k | |
| Independent Director | less than a year | US$114.07k | 0.12% $ 22.2k | |
| Director | less than a year | US$68.06k | no data |
3.9yrs
Average Tenure
49yo
Average Age
Experienced Board: MEIP's board of directors are considered experienced (3.9 years average tenure).